drug

imetelstat

1 story · latest Aug 6, 2026

Status: FDA approved Jun 2024 · NDA217779
Brand: Rytelo
Code: GRN163L
Trials: 3 registered trials in coverage

Relationships

Developed by Geron Corporation

Also known as

imetelstat sodium

Timeline

Geron reports Q2 2026 results as RYTELO revenue climbs to $57.5 million

Aug 6Quarterly updateGeron Corporation imetelstat

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.